首页 > 最新文献

Archivos Peruanos de cardiologia y cirugia cardiovascular最新文献

英文 中文
Coronary heart disease and tuberculosis: an unnoticed syndemia. Review of literature and management proposal. 冠心病与肺结核:未被注意的综合征。文献综述与管理建议。
Pub Date : 2024-06-24 eCollection Date: 2024-04-01 DOI: 10.47487/apcyccv.v5i2.375
Mauricio Andrés Murillo Moreno, Laura Valentina López Gutiérrez, Eric Edward Vinck, Gustavo Roncancio Villamil, Catalina Gallego Muñoz, Clara Inés Saldarriaga Giraldo

Tuberculosis is an increasing disease that affects about one-third of the global population. In line with the rise of tuberculosis, cardiovascular disease has shown a similar trend, with ischemic coronary heart disease becoming the leading cause of death worldwide. Based on the literature, a relationship can be drawn between tuberculosis and ischemic coronary heart disease through their shared multiple risk factors and a possible pathophysiological substrate linking them. The presentation of these two conditions reported so far is varied: it has been found as the onset of acute coronary syndrome in patients with active tuberculosis, the progressive development of coronary atherosclerosis in patients with latent tuberculosis, among others. Given this possible link and the progressive increase in their incidence rates, we can assert that we are facing an unnoticed syndemic, with their concurrent management posing a challenge due to significant pharmacological interactions. The purpose of this review is to clarify this possible link, propose an approach for diagnosis, and provide a treatment algorithm for the entire spectrum of coronary disease coexisting with tuberculosis according to the current available literature.

结核病是一种日益严重的疾病,影响着全球约三分之一的人口。随着结核病的增加,心血管疾病也呈现出类似的趋势,缺血性冠心病已成为全球主要死因。根据文献记载,结核病和缺血性冠心病之间存在着共同的多重危险因素和可能的病理生理基础。迄今所报道的这两种疾病的表现形式多种多样:活动性肺结核患者会出现急性冠状动脉综合征,潜伏性肺结核患者会逐渐出现冠状动脉粥样硬化,等等。鉴于这种可能的联系及其发病率的逐步上升,我们可以断言,我们正面临着一种未被注意到的综合征,由于显著的药理相互作用,其并发症的管理构成了挑战。本综述的目的是澄清这种可能的联系,提出一种诊断方法,并根据现有文献为冠心病与结核病并存的整个病程提供一种治疗算法。
{"title":"Coronary heart disease and tuberculosis: an unnoticed syndemia. Review of literature and management proposal.","authors":"Mauricio Andrés Murillo Moreno, Laura Valentina López Gutiérrez, Eric Edward Vinck, Gustavo Roncancio Villamil, Catalina Gallego Muñoz, Clara Inés Saldarriaga Giraldo","doi":"10.47487/apcyccv.v5i2.375","DOIUrl":"10.47487/apcyccv.v5i2.375","url":null,"abstract":"<p><p>Tuberculosis is an increasing disease that affects about one-third of the global population. In line with the rise of tuberculosis, cardiovascular disease has shown a similar trend, with ischemic coronary heart disease becoming the leading cause of death worldwide. Based on the literature, a relationship can be drawn between tuberculosis and ischemic coronary heart disease through their shared multiple risk factors and a possible pathophysiological substrate linking them. The presentation of these two conditions reported so far is varied: it has been found as the onset of acute coronary syndrome in patients with active tuberculosis, the progressive development of coronary atherosclerosis in patients with latent tuberculosis, among others. Given this possible link and the progressive increase in their incidence rates, we can assert that we are facing an unnoticed syndemic, with their concurrent management posing a challenge due to significant pharmacological interactions. The purpose of this review is to clarify this possible link, propose an approach for diagnosis, and provide a treatment algorithm for the entire spectrum of coronary disease coexisting with tuberculosis according to the current available literature.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e375"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of clinical outcomes of venous thromboembolic disease between outpatient and inpatient management. 静脉血栓栓塞性疾病门诊治疗与住院治疗的临床效果比较。
Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI: 10.47487/apcyccv.v4i4.334
Felipe Aníbal Gregalio, Camila Juana, Gian Manattini Palmili, Bernardo Julio Martínez, Ignacio Martin Bluro, Fernando Javier Vázquez, María Florencia Grande Ratti

Objectives: To compare the occurrence of death, bleeding, and recurrence according to inpatient or outpatient management of venous thromboembolic disease (VTE).

Materials and methods: . Retrospective cohort that included a consecutive sampling of VTE consultations between 2016 and 2019 diagnosed in the Emergency Center of a private hospital in Argentina.

Results: There were 1202 cases, 908 with isolated deep vein thrombosis (DVT), 205 with isolated pulmonary embolism (PE), and 89 cases of combined DVT - PE. 66% were women, with a median age of 77 years; 72% of cases were managed on an outpatient basis (n= 862). Comorbidities associated with hospitalization were obesity (p=0.03), chronic obstructive pulmonary disease (COPD) (p=0.01), heart failure (CHF) (p=0.01), chronic renal failure (CKD) (p=0.01), and cancer (p=0.01). At 90 days, the cumulative incidence of bleeding was 2.6% in inpatient compared to 2.9% in outpatient management (p=0.81); recurrence was 0% versus 0.9% (p=0.07), and mortality was 42.9% versus 18.9%, respectively (p=0.01). The HR for 90-day mortality in hospitalized patients adjusted for confounders (sex, age, type of VTE, obesity, CKD, CHF, COPD, and cancer) was 1.99 (95% CI 1.49-2.64; p=0.01).

Conclusions: In this elderly, and predominantly female Argentine population, the 90-day mortality in patients hospitalized for VTE was higher than mortality in patients with outpatient management, without differences in recurrence or major bleeding.

摘要比较住院或门诊治疗静脉血栓栓塞性疾病(VTE)的死亡、出血和复发情况。回顾性队列,包括2016年至2019年期间在阿根廷一家私立医院急诊中心诊断的VTE就诊连续抽样:共1202例,其中908例为孤立性深静脉血栓(DVT),205例为孤立性肺栓塞(PE),89例合并DVT - PE。66%的病例为女性,中位年龄为 77 岁;72%的病例在门诊治疗(862 例)。与住院相关的合并症有肥胖(p=0.03)、慢性阻塞性肺病(COPD)(p=0.01)、心力衰竭(CHF)(p=0.01)、慢性肾功能衰竭(CKD)(p=0.01)和癌症(p=0.01)。90天后,住院患者的出血累积发生率为2.6%,而门诊患者为2.9%(P=0.81);复发率为0%,而门诊患者为0.9%(P=0.07);死亡率为42.9%,而门诊患者为18.9%(P=0.01)。住院患者的 90 天死亡率经混杂因素(性别、年龄、VTE 类型、肥胖、慢性肾脏病、慢性阻塞性肺病、慢性阻塞性肺病和癌症)调整后的 HR 为 1.99(95% CI 1.49-2.64;P=0.01):在这一以女性为主的阿根廷老年人群中,VTE住院患者的90天死亡率高于门诊患者,但在复发或大出血方面并无差异。
{"title":"Comparison of clinical outcomes of venous thromboembolic disease between outpatient and inpatient management.","authors":"Felipe Aníbal Gregalio, Camila Juana, Gian Manattini Palmili, Bernardo Julio Martínez, Ignacio Martin Bluro, Fernando Javier Vázquez, María Florencia Grande Ratti","doi":"10.47487/apcyccv.v4i4.334","DOIUrl":"https://doi.org/10.47487/apcyccv.v4i4.334","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the occurrence of death, bleeding, and recurrence according to inpatient or outpatient management of venous thromboembolic disease (VTE).</p><p><strong>Materials and methods: </strong>. Retrospective cohort that included a consecutive sampling of VTE consultations between 2016 and 2019 diagnosed in the Emergency Center of a private hospital in Argentina.</p><p><strong>Results: </strong>There were 1202 cases, 908 with isolated deep vein thrombosis (DVT), 205 with isolated pulmonary embolism (PE), and 89 cases of combined DVT - PE. 66% were women, with a median age of 77 years; 72% of cases were managed on an outpatient basis (n= 862). Comorbidities associated with hospitalization were obesity (p=0.03), chronic obstructive pulmonary disease (COPD) (p=0.01), heart failure (CHF) (p=0.01), chronic renal failure (CKD) (p=0.01), and cancer (p=0.01). At 90 days, the cumulative incidence of bleeding was 2.6% in inpatient compared to 2.9% in outpatient management (p=0.81); recurrence was 0% versus 0.9% (p=0.07), and mortality was 42.9% versus 18.9%, respectively (p=0.01). The HR for 90-day mortality in hospitalized patients adjusted for confounders (sex, age, type of VTE, obesity, CKD, CHF, COPD, and cancer) was 1.99 (95% CI 1.49-2.64; p=0.01).</p><p><strong>Conclusions: </strong>In this elderly, and predominantly female Argentine population, the 90-day mortality in patients hospitalized for VTE was higher than mortality in patients with outpatient management, without differences in recurrence or major bleeding.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 1","pages":"13-21"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical predictors of coronary artery bypass graft surgery in patients hospitalized for Non-ST acute coronary syndrome - Buenos Aires I and ReSCAR22 registries. 非 ST 期急性冠状动脉综合征住院患者接受冠状动脉旁路移植手术的临床预测因素 - 布宜诺斯艾利斯 I 和 ReSCAR22 登记。
Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI: 10.47487/apcyccv.v5i1.333.
Julián M Feder, Alan R Sigal, Leonardo A Seoane, Mirza Rivero, Gonzalo Perez, Ezequiel J Zaidel, Fabricio G Procopio, Diego Conde, Juan P Costabel

Objectives: To identify predictors of coronary artery bypass graft surgery (CABG) requirement as a revascularization method in in real-world non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients.

Materials and methods: . An individual pre-specified analysis of patients with NSTE-ACS was performed from two prospective Argentine registries between 2017 and 2022. We analyzed the difference in baseline characteristics between patients who required CABG and those who did not require this intervention. Then, a logistic regression analysis was performed to determine independent predictors in patients who received CABG as a method of revascularization.

Results: A total of 1848 patients with a median age of 54.8 (interquartile range [IQR]: 53.7-56) years and an ejection fraction of 42.1% (IQR: 41.2-43.1) were included. A total of 233 patients required CABG (12.6%). Baseline characteristics between the two groups were similar, except in patients requiring CABG, who were younger (51.5 vs. 55.7 years; p=0.010), more frequently diabetic (38.2% vs. 25.7%; p=0.001) and male (90.1% vs. 73.7%; p=0.001). In addition, they had, to a lesser extent, previous cardiac surgery (2.1% vs. 11.2%; p=0.011). After multivariable analysis, the following were independently associated with CABG: age (Odds Ratio [OR]: 0.99, 95% confidence interval [CI]: 0.98-0.99; p=0.008), male sex (OR: 3.08, 95% CI: 1.87-5.1; p=0.001), history of previous CABG (OR: 0.14, 95% CI: 0.05-0.30; p=0.001) and diabetes (OR: 1.84, 95% CI: 1.31- 2.57; p=0.001).

Conclusions: In this analysis of two NSTEACS registries, younger age, male sex, a diagnosis of diabetes and the absence of previous surgery were independent predictors of the requirement for inpatient CABG.

目的确定现实世界中非 ST 段抬高急性冠状动脉综合征(NSTE-ACS)患者需要进行冠状动脉旁路移植手术(CABG)作为血管再通方法的预测因素。在 2017 年至 2022 年期间,对阿根廷两个前瞻性登记处的 NSTE-ACS 患者进行了单独的预先指定分析。我们分析了需要接受心血管造影术和不需要接受这种干预的患者之间基线特征的差异。然后,我们进行了逻辑回归分析,以确定接受 CABG 作为血管再通方法的患者的独立预测因素:共纳入 1848 名患者,中位年龄为 54.8 岁(四分位间距 [IQR]:53.7-56),射血分数为 42.1%(IQR:41.2-43.1)。共有 233 名患者需要进行 CABG(12.6%)。两组患者的基线特征相似,但需要进行 CABG 的患者更年轻(51.5 岁对 55.7 岁;P=0.010)、更常患糖尿病(38.2% 对 25.7%;P=0.001)和男性(90.1% 对 73.7%;P=0.001)。此外,他们曾接受过心脏手术的比例较低(2.1% 对 11.2%;P=0.011)。经过多变量分析,以下因素与 CABG 独立相关:年龄(Odds Ratio [OR]:0.99,95% 置信区间 [CI]:0.98-0.99;P=0.008)、男性(OR:3.08,95% CI:1.87-5.1;P=0.001)、既往 CABG 病史(OR:0.14,95% CI:0.05-0.30;P=0.001)和糖尿病(OR:1.84,95% CI:1.31- 2.57;P=0.001):在这项对两个 NSTEACS 登记的分析中,年龄较小、男性、糖尿病诊断和既往未接受过手术是住院患者需要接受 CABG 的独立预测因素。
{"title":"Clinical predictors of coronary artery bypass graft surgery in patients hospitalized for Non-ST acute coronary syndrome - Buenos Aires I and ReSCAR22 registries.","authors":"Julián M Feder, Alan R Sigal, Leonardo A Seoane, Mirza Rivero, Gonzalo Perez, Ezequiel J Zaidel, Fabricio G Procopio, Diego Conde, Juan P Costabel","doi":"10.47487/apcyccv.v5i1.333.","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i1.333.","url":null,"abstract":"<p><strong>Objectives: </strong>To identify predictors of coronary artery bypass graft surgery (CABG) requirement as a revascularization method in in real-world non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients.</p><p><strong>Materials and methods: </strong>. An individual pre-specified analysis of patients with NSTE-ACS was performed from two prospective Argentine registries between 2017 and 2022. We analyzed the difference in baseline characteristics between patients who required CABG and those who did not require this intervention. Then, a logistic regression analysis was performed to determine independent predictors in patients who received CABG as a method of revascularization.</p><p><strong>Results: </strong>A total of 1848 patients with a median age of 54.8 (interquartile range [IQR]: 53.7-56) years and an ejection fraction of 42.1% (IQR: 41.2-43.1) were included. A total of 233 patients required CABG (12.6%). Baseline characteristics between the two groups were similar, except in patients requiring CABG, who were younger (51.5 <i>vs.</i> 55.7 years; p=0.010), more frequently diabetic (38.2% <i>vs.</i> 25.7%; p=0.001) and male (90.1% <i>vs.</i> 73.7%; p=0.001). In addition, they had, to a lesser extent, previous cardiac surgery (2.1% <i>vs.</i> 11.2%; p=0.011). After multivariable analysis, the following were independently associated with CABG: age (Odds Ratio [OR]: 0.99, 95% confidence interval [CI]: 0.98-0.99; p=0.008), male sex (OR: 3.08, 95% CI: 1.87-5.1; p=0.001), history of previous CABG (OR: 0.14, 95% CI: 0.05-0.30; p=0.001) and diabetes (OR: 1.84, 95% CI: 1.31- 2.57; p=0.001).</p><p><strong>Conclusions: </strong>In this analysis of two NSTEACS registries, younger age, male sex, a diagnosis of diabetes and the absence of previous surgery were independent predictors of the requirement for inpatient CABG.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pharmacoinvasive strategy in Latin America. Why don't we see it as our option?] [拉丁美洲的药物入侵战略。为什么我们不把它当作我们的选择?]
Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI: 10.47487/apcyccv.v4i4.355
Alexandra Arias-Mendoza
{"title":"[Pharmacoinvasive strategy in Latin America. Why don't we see it as our option?]","authors":"Alexandra Arias-Mendoza","doi":"10.47487/apcyccv.v4i4.355","DOIUrl":"https://doi.org/10.47487/apcyccv.v4i4.355","url":null,"abstract":"","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 1","pages":"61-62"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mechanical circulatory support in cardiogenic shock, a reality in Peru]. [心源性休克的机械循环支持,秘鲁的现实]。
Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.47487/apcyccv.v1i3.84
Leonardo Salazar
{"title":"[Mechanical circulatory support in cardiogenic shock, a reality in Peru].","authors":"Leonardo Salazar","doi":"10.47487/apcyccv.v1i3.84","DOIUrl":"https://doi.org/10.47487/apcyccv.v1i3.84","url":null,"abstract":"","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"1 3","pages":"198-199"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diuretic resistance and heart failure: between congestion and kidney injury]. [利尿剂耐药性与心力衰竭:充血与肾损伤之间]。
Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.47487/apcyccv.v1i3.72
Paola Morejón Barragán

Nowadays, heart Failure (HF) is one of the main contributors of cardiovascular morbidity and mortality, this faces us with great challenges. The heart-kidney interaction receives particular attention due to the development of the so-called cardiorenal syndrome (CRS) and the diuretic resistance, latter is a predictor of adverse events in acute HF and is independent of the glomerular filtration rate. Development of diuretic resistance is secondary to multiple causes, so a comprehensive evaluation of all of them is required. In recent years, congestion has become relevant within the pathophysiological mechanism of CRS, as it mutually generates and perpetuates damage in these two organs. Given the importance of congestion, diuretics remain the cornerstone of treatment, although their use is largely empirical due to the limited evidence available. The evidence-based treatment paradigm is elusive in this scenario, so one question remains unanswered: Do the interventions to treat or to prevent the diuretic resistance modify the prognosis in acute HF?

如今,心力衰竭(HF)是心血管疾病发病率和死亡率的主要诱因之一,这给我们带来了巨大的挑战。由于所谓的心肾综合征(CRS)和利尿剂抵抗的发生,心脏与肾脏的相互作用受到特别关注,后者是急性心力衰竭不良事件的预测因素,与肾小球滤过率无关。利尿剂抵抗的发生继发于多种原因,因此需要对所有原因进行综合评估。近年来,充血已成为 CRS 病理生理机制中的一个重要因素,因为它在这两个器官中相互产生并延续损害。鉴于充血的重要性,利尿剂仍然是治疗的基石,尽管由于证据有限,利尿剂的使用在很大程度上是经验性的。在这种情况下,循证治疗模式难以捉摸,因此有一个问题仍然没有答案:治疗或预防利尿剂耐药的干预措施是否会改变急性心房颤动的预后?
{"title":"[Diuretic resistance and heart failure: between congestion and kidney injury].","authors":"Paola Morejón Barragán","doi":"10.47487/apcyccv.v1i3.72","DOIUrl":"https://doi.org/10.47487/apcyccv.v1i3.72","url":null,"abstract":"<p><p>Nowadays, heart Failure (HF) is one of the main contributors of cardiovascular morbidity and mortality, this faces us with great challenges. The heart-kidney interaction receives particular attention due to the development of the so-called cardiorenal syndrome (CRS) and the diuretic resistance, latter is a predictor of adverse events in acute HF and is independent of the glomerular filtration rate. Development of diuretic resistance is secondary to multiple causes, so a comprehensive evaluation of all of them is required. In recent years, congestion has become relevant within the pathophysiological mechanism of CRS, as it mutually generates and perpetuates damage in these two organs. Given the importance of congestion, diuretics remain the cornerstone of treatment, although their use is largely empirical due to the limited evidence available. The evidence-based treatment paradigm is elusive in this scenario, so one question remains unanswered: Do the interventions to treat or to prevent the diuretic resistance modify the prognosis in acute HF?</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"1 3","pages":"157-164"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Spatial analysis of hypertension in Peruvian adults, 2022]. [秘鲁成年人高血压的空间分析,2022年]。
Pub Date : 2023-06-30 eCollection Date: 2023-04-01 DOI: 10.47487/apcyccv.v4i2.296
Akram Hernández-Vásquez, Brenda Noemí Carrillo Morote, Victoria Del Carmen Azurin Gonzales, Efraín Y Turpo Cayo, Diego Azañedo

Objectives: To perform a spatial analysis of arterial hypertension in the Peruvian adult population to identify geographic patterns with a higher concentration of cases.

Materials and methods: A spatial analysis was conducted using data from the Demographic and Family Health Survey (ENDES) 2022. A sample of 29,422 adults was included, and the global Moran's index and Getis-Ord Gi* analysis were used to evaluate spatial autocorrelation and cluster concentration.

Results: The age-standardized prevalence of arterial hypertension was 19.2%. Clusters with a high concentration of arterial hypertension were observed in departments along the Peruvian coast such as Tumbes, Piura, Lambayeque, La Libertad, Ancash, and Lima, as well as in the northern regions of the Highlands. Clusters were also found in the regions of Loreto and Madre de Dios in the Peruvian jungle.

Conclusions: This study revealed geographic patterns of arterial hypertension in Peru, with a higher concentration of cases along the Peruvian coast and in certain regions of the Highlands and Jungle. These findings highlight the need to develop strategies for the prevention and control of the disease, especially in the areas identified as high-prevalence clusters.

目的:对秘鲁成年人群的动脉高压进行空间分析,以确定病例更集中的地理模式。材料和方法:使用2022年人口和家庭健康调查(ENDES)的数据进行空间分析。纳入29422名成年人的样本,使用全球莫兰指数和Getis Ord-Gi*分析来评估空间自相关和聚类浓度。结果:动脉高压的年龄标准化患病率为19.2%。在秘鲁海岸的图姆斯、皮乌拉、兰巴耶克、拉利伯塔德、安卡什和利马等省以及高地的北部地区,观察到动脉高压高浓度的集群。在秘鲁丛林中的洛雷托和马德雷德迪奥斯地区也发现了集群。结论:这项研究揭示了秘鲁动脉高压的地理模式,秘鲁海岸以及高地和丛林的某些地区的病例更为集中。这些发现突出表明,需要制定预防和控制该疾病的战略,特别是在被确定为高流行率集群的地区。
{"title":"[Spatial analysis of hypertension in Peruvian adults, 2022].","authors":"Akram Hernández-Vásquez,&nbsp;Brenda Noemí Carrillo Morote,&nbsp;Victoria Del Carmen Azurin Gonzales,&nbsp;Efraín Y Turpo Cayo,&nbsp;Diego Azañedo","doi":"10.47487/apcyccv.v4i2.296","DOIUrl":"https://doi.org/10.47487/apcyccv.v4i2.296","url":null,"abstract":"<p><strong>Objectives: </strong>To perform a spatial analysis of arterial hypertension in the Peruvian adult population to identify geographic patterns with a higher concentration of cases.</p><p><strong>Materials and methods: </strong>A spatial analysis was conducted using data from the Demographic and Family Health Survey (ENDES) 2022. A sample of 29,422 adults was included, and the global Moran's index and Getis-Ord Gi* analysis were used to evaluate spatial autocorrelation and cluster concentration.</p><p><strong>Results: </strong>The age-standardized prevalence of arterial hypertension was 19.2%. Clusters with a high concentration of arterial hypertension were observed in departments along the Peruvian coast such as Tumbes, Piura, Lambayeque, La Libertad, Ancash, and Lima, as well as in the northern regions of the Highlands. Clusters were also found in the regions of Loreto and Madre de Dios in the Peruvian jungle.</p><p><strong>Conclusions: </strong>This study revealed geographic patterns of arterial hypertension in Peru, with a higher concentration of cases along the Peruvian coast and in certain regions of the Highlands and Jungle. These findings highlight the need to develop strategies for the prevention and control of the disease, especially in the areas identified as high-prevalence clusters.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"4 2","pages":"48-54"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41143396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac magnetic resonance as a risk re-stratification tool in apical hypertrophic cardiomyopathy. 心脏磁共振作为心尖肥厚型心肌病的风险再分层工具。
Pub Date : 2023-06-30 eCollection Date: 2023-04-01 DOI: 10.47487/apcyccv.v4i2.289
Ana María Larriva, Sandra Rosales Uvera, Zuilma Vásquez, Beatriz Fernández, Diego Xavier Chango Azanza

Apical hypertrophic cardiomyopathy (ApHCM) can result in the formation of a left ventricular apical aneurysm and progressive myocardial fibrosis, which is associated with a worse prognosis. We present the case of a 76-year-old man previously diagnosed with ApHCM seven years ago, who has been under clinical follow-up. Serial cardiac magnetic resonance (CMR) imaging was performed in 2013 and 2020 due to suspected apical aneurysm formation based on echocardiographic evaluation. The 2020 CMR imaging revealed an increase in myocardial fibrosis observed through late-gadolinium enhancement images and, for the first time, a small apical aneurysm that was not clearly visualized on two-dimensional echocardiography. The time course leading to the development of an ApHCM aneurysm is not well-defined and may impact the clinical course.

心尖肥厚型心肌病(ApHCM)可导致左心室心尖动脉瘤的形成和进行性心肌纤维化,这与较差的预后有关。我们报告了一名76岁的男性病例,他在七年前被诊断为ApHCM,目前正在接受临床随访。根据超声心动图评估,由于怀疑心尖动脉瘤形成,于2013年和2020年进行了连续心脏磁共振(CMR)成像。2020年CMR成像显示,通过晚期钆增强图像观察到的心肌纤维化增加,并首次在二维超声心动图上显示出一个未清晰显示的小心尖动脉瘤。导致ApHCM动脉瘤发展的时间进程尚不明确,可能会影响临床进程。
{"title":"Cardiac magnetic resonance as a risk re-stratification tool in apical hypertrophic cardiomyopathy.","authors":"Ana María Larriva,&nbsp;Sandra Rosales Uvera,&nbsp;Zuilma Vásquez,&nbsp;Beatriz Fernández,&nbsp;Diego Xavier Chango Azanza","doi":"10.47487/apcyccv.v4i2.289","DOIUrl":"https://doi.org/10.47487/apcyccv.v4i2.289","url":null,"abstract":"<p><p>Apical hypertrophic cardiomyopathy (ApHCM) can result in the formation of a left ventricular apical aneurysm and progressive myocardial fibrosis, which is associated with a worse prognosis. We present the case of a 76-year-old man previously diagnosed with ApHCM seven years ago, who has been under clinical follow-up. Serial cardiac magnetic resonance (CMR) imaging was performed in 2013 and 2020 due to suspected apical aneurysm formation based on echocardiographic evaluation. The 2020 CMR imaging revealed an increase in myocardial fibrosis observed through late-gadolinium enhancement images and, for the first time, a small apical aneurysm that was not clearly visualized on two-dimensional echocardiography. The time course leading to the development of an ApHCM aneurysm is not well-defined and may impact the clinical course.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"4 2","pages":"78-82"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41154652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atypical presentation of ruptured aneurysmal right sinus of Valsalva with severe aortic insufficiency]. [瓦尔萨尔瓦动脉瘤性右窦破裂伴严重主动脉瓣关闭不全的非典型表现]。
Pub Date : 2023-06-30 eCollection Date: 2023-04-01 DOI: 10.47487/apcyccv.v4i1.284.
Miguel Ángel Serrano-Sánchez, Alfredo Sotomayor-Estrada, W Samir Cubas

Aneurysm of the Sinus of Valsalva (ASV) is a rare abnormality and affects less than 0.1% of the general population. We describe the case of a 37-year-old woman with a clinical picture characterized by dyspnea, palpitations, and syncope of 6 years of evolution. The echocardiographic study revealed a right ASV with a sub pulmonary interventricular perforation of 8mm and producing a regurgitant jet into the right ventricle, causing dilatation of the right ventricular outflow tract, pulmonary artery, and severe aortic insufficiency Carpentier DI. The patient underwent successful repair of the defect and interventricular perforation, and valve replacement was not necessary. Timely echocardiographic diagnosis and early surgery are the main predictors that make the difference between an excellent outcome and certain death.

瓦尔萨尔瓦窦瘤(ASV)是一种罕见的异常,影响不到0.1%的普通人群。我们描述了一例37岁的女性,其临床表现为呼吸困难、心悸和晕厥,经过6年的演变。超声心动图研究显示,右ASV的肺下室间穿孔为8mm,并向右心室产生反流,导致右心室流出道、肺动脉扩张和严重主动脉瓣关闭不全Carpentier DI。患者成功修复了缺损和室间穿孔,无需更换瓣膜。及时的超声心动图诊断和早期手术是区分良好结果和一定死亡的主要预测因素。
{"title":"[Atypical presentation of ruptured aneurysmal right sinus of Valsalva with severe aortic insufficiency].","authors":"Miguel Ángel Serrano-Sánchez,&nbsp;Alfredo Sotomayor-Estrada,&nbsp;W Samir Cubas","doi":"10.47487/apcyccv.v4i1.284.","DOIUrl":"10.47487/apcyccv.v4i1.284.","url":null,"abstract":"<p><p>Aneurysm of the Sinus of Valsalva (ASV) is a rare abnormality and affects less than 0.1% of the general population. We describe the case of a 37-year-old woman with a clinical picture characterized by dyspnea, palpitations, and syncope of 6 years of evolution. The echocardiographic study revealed a right ASV with a sub pulmonary interventricular perforation of 8mm and producing a regurgitant jet into the right ventricle, causing dilatation of the right ventricular outflow tract, pulmonary artery, and severe aortic insufficiency Carpentier DI. The patient underwent successful repair of the defect and interventricular perforation, and valve replacement was not necessary. Timely echocardiographic diagnosis and early surgery are the main predictors that make the difference between an excellent outcome and certain death.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"4 2","pages":"68-71"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41164633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of cardiac surgeries and operative mortality at the National Cardiovascular Institute during 2022]. 【2022年美国国家心血管研究所心脏手术和手术死亡率分析】。
Pub Date : 2023-06-30 eCollection Date: 2023-04-01 DOI: 10.47487/apcyccv.v4i2.287
Gerber Polo-Gutierrez, Harod Anders Silva-Tejada, Franklin Willy Martinez-Ninanqui, Victor Robles-Velarde, Josías Ríos-Ortega

Objective: To describe cardiac surgeries, their approaches, and determine operative mortality according to the type of surgery and the main complications recorded within 30 days postoperatively, performed at the National Cardiovascular Institute of Peru.

Materials and methods: A descriptive study was conducted on all patients over 18 years of age who underwent cardiovascular surgery at the National Cardiovascular Institute "Carlos Alberto Peschiera Carrillo".

Results: During the year 2022, a total of 503 cardiac surgeries were performed. Of the patients undergoing surgery, 63.6% (320) were males. Isolated valvular surgery, primarily aortic or mitral valve replacement, was the most frequent surgical procedure, with 136 surgeries (27.0%). This was followed by myocardial revascularization surgery with 110 procedures (21.9%). Throughout the year, there were 23 deaths, resulting in an overall mortality rate of 4.5%. The mortality rate for elective surgeries was 2.8%, while for emergency surgeries, it was 14.3%. The most common complication was paroxysmal atrial fibrillation (14.0%), followed by surgical site infection with 52 cases (10.3%).

Conclusions: Valvular surgery, whether isolated or combined with other procedures, was the most frequently performed. The obtained mortality rate is considered acceptable for a reference center.

目的:描述心脏手术及其方法,并根据手术类型和术后30天内记录的主要并发症确定手术死亡率,材料和方法:对在国家心血管研究所“Carlos Alberto Peschiera Carrillo”接受心血管手术的所有18岁以上患者进行了描述性研究。结果:2022年,共进行了503次心脏手术。在接受手术的患者中,63.6%(320)为男性。孤立性瓣膜手术,主要是主动脉瓣或二尖瓣置换术,是最常见的手术,共有136例(27.0%)。其次是心肌血运重建手术,共110例(21.9%)。全年共有23例死亡,总死亡率为4.5%。选择性手术的死亡率为2.8%,急诊手术发生率为14.3%,最常见的并发症为阵发性心房颤动(14.0%),其次为手术部位感染52例(10.3%)。所获得的死亡率被认为是参考中心可以接受的。
{"title":"[Analysis of cardiac surgeries and operative mortality at the National Cardiovascular Institute during 2022].","authors":"Gerber Polo-Gutierrez,&nbsp;Harod Anders Silva-Tejada,&nbsp;Franklin Willy Martinez-Ninanqui,&nbsp;Victor Robles-Velarde,&nbsp;Josías Ríos-Ortega","doi":"10.47487/apcyccv.v4i2.287","DOIUrl":"https://doi.org/10.47487/apcyccv.v4i2.287","url":null,"abstract":"<p><strong>Objective: </strong>To describe cardiac surgeries, their approaches, and determine operative mortality according to the type of surgery and the main complications recorded within 30 days postoperatively, performed at the National Cardiovascular Institute of Peru.</p><p><strong>Materials and methods: </strong>A descriptive study was conducted on all patients over 18 years of age who underwent cardiovascular surgery at the National Cardiovascular Institute \"Carlos Alberto Peschiera Carrillo\".</p><p><strong>Results: </strong>During the year 2022, a total of 503 cardiac surgeries were performed. Of the patients undergoing surgery, 63.6% (320) were males. Isolated valvular surgery, primarily aortic or mitral valve replacement, was the most frequent surgical procedure, with 136 surgeries (27.0%). This was followed by myocardial revascularization surgery with 110 procedures (21.9%). Throughout the year, there were 23 deaths, resulting in an overall mortality rate of 4.5%. The mortality rate for elective surgeries was 2.8%, while for emergency surgeries, it was 14.3%. The most common complication was paroxysmal atrial fibrillation (14.0%), followed by surgical site infection with 52 cases (10.3%).</p><p><strong>Conclusions: </strong>Valvular surgery, whether isolated or combined with other procedures, was the most frequently performed. The obtained mortality rate is considered acceptable for a reference center.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"4 2","pages":"55-61"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archivos Peruanos de cardiologia y cirugia cardiovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1